CITATIONS


JOP. J Pancreas (Online) 2005; 6(4):369-374.

Hemolytic-Uremic Syndrome Associated with Gemcitabine: A Case Report and Review of Literature

Saif MW, McGee PJ

Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham (UAB). Birmingham, AL, USA


Cited by:

5

Kalra N, Kad R, Osama S. Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma. Int J Clin Oncol 2007; 12(5):385-7. [More details]

4

Zupancic M, Shah PC, Shah-Khan F. Gemcitabine-associated thrombotic thrombocytopenic purpura. Lancet Oncol 2007; 8(7):634-41. [More details]

3

Schenk PW, Cransberg K, Wolff ED, de Rijke YB. Point-of-care creatinine testing in children at risk for sudden deterioration of renal function. Clin Chem Lab Med 2007; 45(11):1536-41. [More details]

2

Saif MW, Shahrokni A, Cornfeld D. Gemcitabine-Induced Liver Fibrosis in a Patient with Pancreatic Cancer. JOP. J Pancreas (Online) 2007; 8(4):460-467. [More details]

1

Karie S, Launay-Vacher V, Izzedine H, Deray G. Drud-induced nephrotoxicity: bibliography from January 2003 to December 2005. Nephrol Ther 2006; 2(6):368-378. [More details]